Definitive Healthcare Corp. (NASDAQ:DH) is a company that provides data, analytics, and insights to healthcare organizations. It helps its clients make informed decisions by offering comprehensive healthcare commercial intelligence. In the competitive landscape, DH faces peers like Thoughtworks Holding, Inc. (TWKS), LifeStance Health Group, Inc. (LFST), Clearwater Analytics Holdings, Inc. (CWAN), Cytek Biosciences, Inc. (CTKB), and AvidXchange Holdings, Inc. (AVDX).
In evaluating DH's financial efficiency, its Return on Invested Capital (ROIC) is -76.31%, while its Weighted Average Cost of Capital (WACC) is 8.79%. This results in a ROIC to WACC ratio of -8.68, indicating a significant inefficiency in generating returns relative to its cost of capital. This is the most negative ratio among its peers, highlighting a substantial challenge for DH.
Comparatively, Thoughtworks Holding, Inc. (TWKS) has a ROIC of -3.79% and a WACC of 9.10%, leading to a ROIC to WACC ratio of -0.42. Although TWKS also struggles with inefficiency, its ratio is less negative than DH's, suggesting a relatively better performance in managing its capital costs.
LifeStance Health Group, Inc. (LFST) stands out with the least negative ROIC to WACC ratio of -0.0011, despite a ROIC of -0.009% and a WACC of 8.27%. This indicates that LFST has the smallest disparity between its returns and capital costs among the companies analyzed, showcasing a more efficient capital management approach compared to DH.
Other peers like Clearwater Analytics Holdings, Inc. (CWAN) and Cytek Biosciences, Inc. (CTKB) also exhibit negative ROIC to WACC ratios of -0.042 and -0.55, respectively. However, these figures are still less severe than DH's, further emphasizing the challenges DH faces in achieving financial efficiency.
